Search

Developed by scientists at MSK and the University of British Columbia/BC Cancer, the platform provides the deepest look yet into tumor evolution.

A preclinical study published in the journal Molecular Therapy by researchers at Memorial Sloan Kettering (MSK) provides evidence that radiation therapy could improve the efficacy of CAR T cell therapy for solid tumors.

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed its ninth class of PhD students on July 21, 2014.

New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.

Early-onset colorectal cancer (CRC) is likely clinically and genomically indistinguishable from average-onset cancer, according to a recent study published in the Journal of the National Cancer Institute by MSK investigators.

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.

People with prostate cancer can benefit from exercise in more ways than they might expect.